« Electile Dysfunction | Main | Value-Based Insurance Design »
December 13, 2007
Carba Loading
by Peter Pitts
Personalized medicine? Yes please.
Carbamazepine Prescribing Information to Include Recommendation of Genetic Test for Patients with Asian Ancestry
Connection of genetic information with medication use can improve safe use of product
The U.S. Food and Drug Administration today announced that the manufacturers of drugs containing the active ingredient carbamazepine have agreed to add to the drugs' labeling a recommendation that, before starting therapy with the drugs, patients with Asian ancestry get a genetic blood test that can identify a significantly increased risk of developing a rare, but serious, skin reaction.
The full FDA press release can be found here:
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01755.html
"Science is now letting us individually treat patients based on how their body might react to a drug," said Janet Woodcock, M.D., FDA's deputy commissioner for scientific and medical programs, chief medical officer, and acting director of the Center for Drug Evaluation and Research. "When being considered for treatment with carbamazepine, genetically high-risk patients can be given a test that will help their health care providers make personalized drug treatment decisions and help avoid potentially serious skin reactions."
Posted by peterpitts at December 13, 2007 08:12 AM
Trackback Pings
TrackBack URL for this entry:
/cgi-bin/mt-tb.cgi/160
